Sanofi
SAN | PA
Overview
Corporate Details
- ISIN(s):
- FR0000120578 (+39 more)
- LEI:
- 549300E9PC51EN656011
- Country:
- France
- Address:
- 46 AVENUE DE LA GRANDE ARMEE, 75017 PARIS
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Sanofi S.A. is a French multinational healthcare company headquartered in Paris, France. Originally, the corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical drugs principally in the prescription market, but the firm also develops over-the-counter medication. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines (it is the world's largest producer of the latter through its subsidiary Sanofi Pasteur).
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-11 18:30 |
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
|
English | 3.0 MB | |
| 2025-08-04 18:30 |
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
|
English | 3.1 MB | |
| 2025-08-04 18:30 |
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
|
English | 3.1 MB | |
| 2025-07-31 18:20 |
Report Publication Announcement
Press release: Online availability of Sanofi’s half-year financial report for 2…
|
English | 115.2 KB | |
| 2025-07-31 18:20 |
Report Publication Announcement
Communiqué de presse : Mise en ligne du rapport financier semestriel 2025 de Sa…
|
French | 115.0 KB | |
| 2025-07-31 00:00 |
Interim Report
Sanofi - Rapport semestriel 2025
|
French | 1.6 MB | |
| 2025-07-22 07:30 |
M&A Activity
Communiqué de presse : Sanofi va acquérir Vicebio et enrichir son pipeline de v…
|
French | 193.0 KB | |
| 2025-07-22 07:30 |
M&A Activity
Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeli…
|
English | 193.8 KB | |
| 2025-07-21 18:30 |
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
|
English | 2.7 MB | |
| 2025-07-21 18:30 |
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
|
English | 2.7 MB | |
| 2025-07-09 18:29 |
Declaration of Voting Results & Voting Rights Announcements
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Juin …
|
French | 119.8 KB | |
| 2025-07-09 18:29 |
Declaration of Voting Results & Voting Rights Announcements
Sanofi: Information concerning the total number of voting rights and shares - J…
|
English | 143.7 KB | |
| 2025-06-30 21:33 |
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
|
English | 2.7 MB | |
| 2025-06-30 21:33 |
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
|
English | 2.7 MB | |
| 2025-06-30 07:30 |
Report Publication Announcement
Communiqué de presse : Mise en ligne du document «Q2 2025 Aide mémoire »
|
French | 149.2 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-05-02 | N/A | Other | Buy | 71,423 | N/A |
| 2024-04-26 | N/A | Other | Buy | 1,000 | 91,380.00 EUR |
| 2023-06-09 | N/A | Other | Buy | 9 | 856.04 EUR |
| 2023-05-02 | N/A | Other | Buy | 65,205 | 6,364,008.00 EUR |
| 2023-05-02 | N/A | Other | Buy | 500 | 48,835.00 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |